Sleater J P, Segal G H, Scott M D, Masih A S
Department of Pathology and Laboratory Medicine, University of Florida, Gainesville.
Mod Pathol. 1994 Jun;7(5):593-8.
Angiotropic lymphoma is a rare, aggressive, intravascular non-Hodgkin's lymphoma, usually of B-cell phenotype. Because lymphoma is often clinically unsuspected, the small skin or muscle biopsies typically obtained for evaluation make assessment of lymphoid clonality through cell surface markers or Southern blot hybridization analysis difficult or impossible. The recent development of polymerase chain reaction methodologies to detect chromosomal translocations and immunoglobulin heavy chain gene rearrangement on paraffin-embedded tissue offers an attractive alternative for ascertaining the clonality of lymphoproliferative processes. We report a case of B-cell angiotropic lymphoma in which a monoclonal variable diversity joining region rearrangement of the immunoglobulin heavy chain locus was detected by polymerase chain reaction in both ante- and postmortem, formalin-fixed, paraffin-embedded skeletal muscle. The use of polymerase chain reaction in assessing clonality in angiotropic lymphoma is enhanced by the general absence of a background of reactive B-lymphoid cells in angiotropic lymphoma, which can obscure the monoclonal band and/or compromise sensitivity. No amplification product was obtained for t(14;18) involving the bcl-2 major breakpoint region. It is interesting to note that this case exhibited rare circulating lymphoma cells and more extensive bone marrow involvement (more than 100 tumor cells/high magnification field) than has been previously described.
血管中心性淋巴瘤是一种罕见的、侵袭性血管内非霍奇金淋巴瘤,通常为B细胞表型。由于淋巴瘤在临床上常常难以被怀疑,通常用于评估的小皮肤或肌肉活检组织,通过细胞表面标志物或Southern印迹杂交分析来评估淋巴样克隆性很困难或无法进行。最近发展的聚合酶链反应方法可检测石蜡包埋组织中的染色体易位和免疫球蛋白重链基因重排,为确定淋巴增殖性病变的克隆性提供了一种有吸引力的替代方法。我们报告了一例B细胞血管中心性淋巴瘤病例,在生前和死后福尔马林固定、石蜡包埋的骨骼肌中,通过聚合酶链反应检测到免疫球蛋白重链基因座的单克隆可变区连接区重排。血管中心性淋巴瘤中一般不存在反应性B淋巴细胞背景,而这种背景会模糊单克隆条带和/或损害敏感性,因此聚合酶链反应在评估血管中心性淋巴瘤克隆性方面的应用得到了加强。未获得涉及bcl-2主要断裂点区域的t(14;18)扩增产物。值得注意的是,该病例显示出罕见的循环淋巴瘤细胞,且骨髓受累范围比之前描述的更广泛(每高倍视野超过100个肿瘤细胞)。